Type 2 Studies

Grade – This study is designed to help find the best combination drug treatment for people with type 2 diabetes. For more information please click here or please contact:

Sonia Guarda

984-974-3003

Sonia.guarda@unc.edu

www.gradestudy.com 

 

Theracos – The purpose of this study is to test a drug called Bexaglifozin for patients with Type 2 Diabetes that have an increased risk of cardiovascular disease. For more information please click here or contact:

Katarina Vukojicic

984-974-3008

Katarina_vukojicic@med.unc.edu

 

Derive – The purpose of this study is to evaluate the effectiveness of lowering blood sugar and kidney safety of Dapagliflozin in patients with Type 2 Diabetes and Chronic Kidney Disease (CKD 3A). For more information please click here or contact:

Katarina Vukojicic

984-974-3008

Katarina_vukojicic@med.unc.edu

 

Fidelio/Figaro - The purpose of this study is to investigate the effectiveness and safety of finerenone, a blood pressure medicine, in patients with Type 2 Diabetes and Diabetic Kidney Disease. For more information please click here or contact:

Katarina Vukojicic / Jamie Diner

984-974-3008 / 984-974-3017

Katarina_vukojicic@med.unc.edu / diner@med.unc.edu

 

Pioneer 7 – The purpose of this study is to look at the efficiency and safety of oral Semaglutide compare to Sitagliptin in subjects with Type 2 Diabetes. For more information contact:

Alex Kass

984-974-3009

Alex_kass@med.unc.edu

 

 BACK TO RESEARCH